Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs retinal photocoagulation for retinopathy of prematurity (MBROP)
jRCT2091220073Recruiting
- Sponsor
- Nobuhisa Naoi,MD Department of Ophthalmology,School of Medicine University of Miyazaki
- Start
- Oct 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of bevacizumab in retinopathy of prematurity (ROP) (2 arms), sponsored by Nobuhisa Naoi,MD Department of Ophthalmology,School of Medicine University of Miyazaki. Primary endpoint: retinal status. Started Oct 2011; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on jRCT2091220073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220073.